Current filters:

GenericsRare diseases

Cornerstone Thera gets US rights to Chiesi's Bethkis


USA-based specialty pharma firm Cornerstone Therapeutics Inc. (Nasdaq: CRTX) says it has entered into…

BethkisChiesi FarmaceuticiCornerstone TherapeuticsGenericsLicensingNorth AmericaPharmaceuticalRare diseasesRespiratory and Pulmonary

US FDA approves CSL Behring’s Corifact; warns on pre-term use of terbutaline


The US Food and Drug Administration has approved Corifact, the first product intended to prevent bleeding…

CorifactCSL BehringGenericsNorth AmericaPharmaceuticalRare diseasesRegulationReproductiveRespiratory and Pulmonaryterbutaline

Russian changes in regulation of pharmaceutical circulation now in place


Changes to the regulation of the Russian pharmaceutical market are coming into effect or have been proposed…

EuropeGenericsLegalPharmaceuticalRare diseasesRegulationResearch

Back to top